MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BMRN has $7,614,868K in assets. $1,558,157K in debts. $1,250,108K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
482.76%
Quick Ratio
309.65%
Cash Ratio
156.57%
Debt to Asset Ratio
20.46%
Assets Breakdown
    • Deferred tax assets
    • Inventory
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accounts payable and accrued lia...
    • Long-term convertible debt, net
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Cash and cash equivalents
1,250,108 1,213,816 1,048,803 942,842
Short-term investments
227,731 218,309 223,532 194,864
Accounts receivable, net
790,266 855,855 739,177 660,535
Inventory
1,382,173 1,340,169 1,274,848 1,232,653
Other current assets
204,265 177,183 181,545 201,533
Total current assets
3,854,543 3,805,332 3,467,905 3,232,427
Long-term investments
512,937 508,592 506,724 521,238
Property, plant and equipment, net
1,038,187 1,030,385 1,032,613 1,043,041
Intangible assets, net
233,112 239,620 247,346 255,278
Goodwill
196,199 196,199 196,199 196,199
Deferred tax assets
1,509,109 1,427,021 1,460,566 1,489,366
Other assets
270,781 249,192 235,654 251,391
Total assets
7,614,868 7,456,341 7,147,007 6,988,940
Accounts payable and accrued liabilities
798,438 684,247 628,213 606,988
Short-term convertible debt, net
---0
Total current liabilities
798,438 684,247 628,213 606,988
Long-term convertible debt, net
596,663 596,162 595,650 595,138
Other long-term liabilities
163,056 148,819 129,685 128,824
Total liabilities
1,558,157 1,429,228 1,353,548 1,330,950
Common stock, 0.001 par value 500,000,000 shares authorized 192,098,751 and 190,761,349 shares issued and outstanding, respectively
192 192 192 191
Additional paid-in capital
5,900,968 5,851,637 5,794,302 5,802,068
Company common stock held by the nonqualified deferred compensation plan
11,291 11,674 11,177 11,227
Accumulated other comprehensive income (loss)
-33,937 -44,565 19,151 61,653
Retained earnings (accumulated deficit)
200,779 231,523 -9,009 -194,695
Total stockholders equity
6,056,711 6,027,113 5,793,459 5,657,990
Total liabilities and stockholders equity
7,614,868 7,456,341 7,147,007 6,988,940
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other current assets$204,265K Inventory$1,382,173K Accounts receivable, net$790,266K Short-term investments$227,731K Cash and cashequivalents$1,250,108K Other assets$270,781K Deferred tax assets$1,509,109K Goodwill$196,199K Intangible assets, net$233,112K Property, plant andequipment, net$1,038,187K Long-term investments$512,937K Total current assets$3,854,543K Total assets$7,614,868K Total liabilities andstockholders equity$7,614,868K Total stockholdersequity$6,056,711K Total liabilities$1,558,157K Accumulated othercomprehensive income (loss)-$33,937K Company common stockheld by the...$11,291K Retained earnings(accumulated deficit)$200,779K Additional paid-in capital$5,900,968K Other long-termliabilities$163,056K Long-term convertibledebt, net$596,663K Total currentliabilities$798,438K Common stock, 0.001 parvalue 500,000,000...$192K Accounts payable andaccrued liabilities$798,438K

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)